Fig. 2.

Plasma eltrombopag concentration stratified by Child–Pugh class in the 12.5 mg (a), 25 mg (b), and 37.5 mg groups (c). One patient in the 12.5 mg group with Child–Pugh class A and another patient in the 37.5 mg group with Child–Pugh class B were excluded from summary statistics of plasma concentration, because both patients had used a cation-containing antacid, which affects the exposure of eltrombopag. Data are expressed as means ± SD